EP Wealth Advisors LLC purchased a new stake in Koninklijke Philips (NYSE:PHG – Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 6,270 shares of the technology company’s stock, valued at approximately $205,000.
Other institutional investors and hedge funds also recently modified their holdings of the company. Cetera Advisors LLC acquired a new position in Koninklijke Philips during the 1st quarter worth approximately $273,000. CWM LLC boosted its holdings in Koninklijke Philips by 21.9% during the second quarter. CWM LLC now owns 3,429 shares of the technology company’s stock worth $86,000 after purchasing an additional 616 shares during the last quarter. SG Americas Securities LLC grew its position in Koninklijke Philips by 3.4% in the second quarter. SG Americas Securities LLC now owns 30,698 shares of the technology company’s stock valued at $774,000 after purchasing an additional 1,013 shares in the last quarter. Sequoia Financial Advisors LLC acquired a new stake in Koninklijke Philips in the 2nd quarter valued at $217,000. Finally, Envestnet Portfolio Solutions Inc. lifted its position in Koninklijke Philips by 12.9% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 26,515 shares of the technology company’s stock worth $668,000 after buying an additional 3,040 shares in the last quarter. 13.67% of the stock is owned by institutional investors and hedge funds.
Koninklijke Philips Stock Performance
Shares of PHG opened at $25.79 on Friday. The company has a market cap of $24.24 billion, a PE ratio of -61.40, a price-to-earnings-growth ratio of 0.93 and a beta of 0.76. The firm has a 50-day moving average of $28.13 and a 200-day moving average of $28.20. Koninklijke Philips has a one year low of $19.55 and a one year high of $32.91. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74.
Analyst Upgrades and Downgrades
Get Our Latest Research Report on PHG
Koninklijke Philips Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories
- Five stocks we like better than Koninklijke Philips
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Which Wall Street Analysts are the Most Accurate?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Why Invest in 5G? How to Invest in 5G Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHG – Free Report).
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.